Completed NA INTERVENTIONAL 1-arm NCT00848562

Nicorandil Study to Reduce Cardiac Death After Percutaneous Coronary Intervention (PCI) in Hemodialysis Patients

Oral Nicorandil to Reduce Cardiac Death After Coronary Revascularization in Hemodialysis Patients: A Randomized Trial

Sponsor: Toujinkai Hospital

Conditions Acute Myocardial Infarction Congestive Heart Failure

Interventions Nicorandil

Updated 4 times since 2017 Last updated: Feb 19, 2009 Started: Jan 31, 2002 Primary completion: Dec 31, 2006 Completion: Dec 31, 2006

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This NA trial investigates Acute Myocardial Infarction and Congestive Heart Failure and is currently completed. Toujinkai Hospital leads this study, which shows 4 recorded versions since 2002 — indicating limited longitudinal coverage. Heart and vascular conditions benefit from the kind of long-term tracking this trial provides.

Status Flow

Change History

4 versions recorded

Sep 2024 — Present [monthly]

Completed NA
Jul 2024 — Sep 2024 [monthly]

Completed NA
Jan 2021 — Jul 2024 [monthly]

Completed NA
Jan 2017 — Jan 2021 [monthly]

Completed NA

First recorded

Jan 2002

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Toujinkai Hospital

Data source: Toujinkai Hospital

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Kyoto, Japan